Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

2015 ◽  
Vol 16 (7) ◽  
pp. 830-838 ◽  
Author(s):  
James C-H Yang ◽  
Lecia V Sequist ◽  
Sarayut Lucien Geater ◽  
Chun-Ming Tsai ◽  
Tony Shu Kam Mok ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Egfr Mutations ◽  
Clinical Activity ◽  
Small Cell Lung ◽  
Post Hoc Analysis ◽  
Post Hoc

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

2018 ◽  
Vol 19 (1) ◽  
pp. 93-104 ◽  
Author(s):  
Sara Pilotto ◽  
Antonio Rossi ◽  
Tiziana Vavalà ◽  
Alessandro Follador ◽  
Marcello Tiseo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
First Generation ◽  
Small Cell ◽  
Egfr Mutations ◽  
Small Cell Lung ◽  
Post Hoc Analysis ◽  
Positive Study ◽  
Post Hoc ◽  
Egfr Tkis
Sign in / Sign up

Export Citation Format

Share Document